Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-000806

COO and General Counsel sold 37,184 shares at an average $19.80 ($736,059)

  • COO and General Counsel acquired 100,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Brien Patrick · COO and General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-04 Grant or award : show line 1 in the form 10b5-1 +100,000 564,385 D
2025-01-06 Sale : show line 2 in the form 10b5-1 −19,658 $19.69 $387,066 544,727 D
2025-01-06 Sale : show line 3 in the form 10b5-1 −9,526 $20.10 $191,473 535,201 D
2025-01-07 Sale : show line 4 in the form 10b5-1 −8,000 $19.69 $157,520 527,201 D
Open-market sales · 37,184 sh · avg $19.80 · $736,059
Loading xslF345X05/wk-form4_1736303281.xml…